# A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions

**Authors:** Tao Wang, Cynthia Daoud, Auriane Dubois, Guillaume Corre, Jessica Bellec, Matteo Bovolenta, Louise Philidet, Alan Dorval, Nathalie Bourg, Carinne Roudaut, Sonia Albini, Ganesh Warthi, Abbass Jaber, Isabelle Richard

PMC · DOI: 10.1242/dmm.052578 · Disease Models & Mechanisms · 2026-02-04

## TL;DR

A new rat model with a DMD gene deletion mimics human DMD and shows natural exon skipping that reduces disease severity.

## Contribution

A novel rat model with an exon 45 deletion and spontaneous exon skipping is developed to study DMD and therapeutic strategies.

## Key findings

- DmdΔ45 rats show progressive muscle and cardiac dysfunction with age.
- Spontaneous exon skipping of exon 44 partially restores dystrophin expression.
- Transcriptomic changes reflect chronic inflammation and metabolic dysfunction.

## Abstract

Pathogenic variants in the dystrophin (DMD) gene cause muscle-wasting disorders ranging from the milder Becker muscular dystrophy (BMD) to the more severe Duchenne muscular dystrophy (DMD). Exon 45 deletion is the most-frequent single-exon deletion in patients diagnosed with DMD. Here, we generated a novel rat model with an exon 45 deletion using CRISPR/Cas9. The DmdΔ45 rat recapitulate key features of DMD, including progressive skeletal muscle degeneration, impaired muscle and cardiac function, and cognitive deficits. Transcriptomics analyses revealed gene expression patterns consistent with dystrophin deficiency. In skeletal muscle, we observed a transition from early stress responses and regeneration to chronic inflammation, fibrosis and metabolic dysfunction. Cardiac profiles similarly progressed from early inflammatory responses to fibrotic remodelling and metabolic impairment. Notably, DmdΔ45 rats displayed a milder phenotype than other DMD rat models. This attenuation is likely due to spontaneous exon skipping, particularly of exon 44, which partially restores the reading frame and increases revertant dystrophin-positive fibres with age. Downregulation of spliceosome-related genes suggests a potential mechanism for this exon skipping. Overall, this model provides valuable insights into phenotypic variability and therapeutic exon-skipping strategies.

Summary: A new rat model of Duchenne muscular dystrophy with exon 45 deletion reveals progressive muscle and heart disease, while uncovering natural exon skipping that attenuates disease severity.

## Linked entities

- **Genes:** DMD (dystrophin) [NCBI Gene 1756]
- **Proteins:** LYZ (lysozyme)
- **Diseases:** Duchenne muscular dystrophy (MONDO:0010679), Becker muscular dystrophy (MONDO:0010311)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Dmd (dystrophin) [NCBI Gene 24907] {aka DNADMD1}
- **Diseases:** skeletal muscle degeneration (MESH:D005207), impaired muscle and cardiac function (MESH:D009135), cognitive deficits (MESH:D003072), fibrosis (MESH:D005355), inflammation (MESH:D007249), metabolic dysfunction (MESH:D008659), BMD (MESH:D020388), fibrotic remodelling (MESH:D020257)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919952/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919952/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919952/full.md

---
Source: https://tomesphere.com/paper/PMC12919952